ArticleThe Journal of clinical investigation2023

UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer.

Jun Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.